BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Z, Ji M, Wang Q, He N, Li Y. Ca2+ signaling modulation using cancer cell membrane coated chitosan nanoparticles to combat multidrug resistance of cancer. Carbohydr Polym 2020;238:116073. [PMID: 32299562 DOI: 10.1016/j.carbpol.2020.116073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Patra P, Rengan AK. Cancer cell membrane cloaked nanocarriers: A biomimetic approach towards cancer theranostics. Materials Today Communications 2022;33:104289. [DOI: 10.1016/j.mtcomm.2022.104289] [Reference Citation Analysis]
2 Lei J, Deng F, Ding H, Fu M, Xu T, Ji B, Feng L, Li M, Qiu J, Gao Q. Recent Developments on the Roles of Calcium Signals and Potential Therapy Targets in Cervical Cancer. Cells 2022;11:3003. [DOI: 10.3390/cells11193003] [Reference Citation Analysis]
3 Ashrafizadeh M, Hushmandi K, Mirzaei S, Bokaie S, Bigham A, Makvandi P, Rabiee N, Thakur VK, Kumar AP, Sharifi E, Varma RS, Aref AR, Wojnilowicz M, Zarrabi A, Karimi‐maleh H, Voelcker NH, Mostafavi E, Orive G. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10325] [Reference Citation Analysis]
4 Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]
6 Guo K, Xiao N, Liu Y, Wang Z, Tóth J, Gyenis J, Thakur VK, Oyane A, Shubhra QT. Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: Opportunities and challenges. Nano Materials Science 2021. [DOI: 10.1016/j.nanoms.2021.12.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Chen M, Cui Y, Hao W, Fan Y, Zhang J, Liu Q, Jiang M, Yang Y, Wang Y, Gao C. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy. Drug Deliv 2021;28:2241-55. [PMID: 34668811 DOI: 10.1080/10717544.2021.1992038] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Li M, Zhao Y, Zhang W, Zhang S, Zhang S. Multiple-therapy strategies via polysaccharides-based nano-systems in fighting cancer. Carbohydr Polym 2021;269:118323. [PMID: 34294335 DOI: 10.1016/j.carbpol.2021.118323] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Li A, Zhao Y, Li Y, Jiang L, Gu Y, Liu J. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Deliv 2021;28:1237-55. [PMID: 34142930 DOI: 10.1080/10717544.2021.1938757] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
10 Prateeksha, Sharma VK, Liu X, Oyarzún DA, Abdel-Azeem AM, Atanasov AG, Hesham AE, Barik SK, Gupta VK, Singh BN. Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics. Semin Cancer Biol 2021:S1044-579X(21)00151-6. [PMID: 34062265 DOI: 10.1016/j.semcancer.2021.05.021] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Hussain Z, Rahim MA, Jan N, Shah H, Rawas-Qalaji M, Khan S, Sohail M, Thu HE, Ramli NA, Sarfraz RM, Abourehab MAS. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy. J Control Release 2021;335:130-57. [PMID: 34015400 DOI: 10.1016/j.jconrel.2021.05.018] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
12 Ashrafizadeh M, Delfi M, Hashemi F, Zabolian A, Saleki H, Bagherian M, Azami N, Farahani MV, Sharifzadeh SO, Hamzehlou S, Hushmandi K, Makvandi P, Zarrabi A, Hamblin MR, Varma RS. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydr Polym 2021;260:117809. [PMID: 33712155 DOI: 10.1016/j.carbpol.2021.117809] [Cited by in Crossref: 13] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
13 Gao H, Cheng R, A. Santos H. Nanoparticle‐mediated siRNA delivery systems for cancer therapy. VIEW 2021;2:20200111. [DOI: 10.1002/viw.20200111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zhang XK, Wang QW, Xu YJ, Sun HM, Wang L, Zhang LX. Co-delivery of cisplatin and oleanolic acid by silica nanoparticles-enhanced apoptosis and reverse multidrug resistance in lung cancer. Kaohsiung J Med Sci 2021;37:505-12. [PMID: 33559348 DOI: 10.1002/kjm2.12365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ahmad MZ, Rizwanullah M, Ahmad J, Alasmary MY, Akhter MH, Abdel-wahab BA, Warsi MH, Haque A. Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2020.1869737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
16 Jia L, Li Z, Zheng D, Li Z, Zhao Z. A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells. Carbohydrate Polymers 2021;251:117008. [DOI: 10.1016/j.carbpol.2020.117008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
17 Huang BH, Li SY, Chiang TT, Wu PW. Leveraging the water electrolysis reaction in bipolar electrophoresis to form robust and defectless chitosan films. Carbohydr Polym 2020;250:116912. [PMID: 33049832 DOI: 10.1016/j.carbpol.2020.116912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang L, Xu B. Autophagy inhibitior autophagy-related 7 small interfering RNA and doxorubicin dual-loaded nanostructured lipid carrier to combat multidrug resistance. J Mater Res 2020;35:3136-43. [DOI: 10.1557/jmr.2020.223] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Chen J, Huang J. Sorafenib delivered by cancer cell membrane remodels tumor microenvironment to enhances the immunotherapy of mitoxantrone in breast cancer. J Mater Res 2020;35:3296-303. [DOI: 10.1557/jmr.2020.321] [Reference Citation Analysis]
20 Zhang H, Wang X, Guo Y, Liu X, Zhao X, Teka T, Lv C, Han L, Huang Y, Pan G. Thirteen bisbenzylisoquinoline alkaloids in five Chinese medicinal plants: Botany, traditional uses, phytochemistry, pharmacokinetic and toxicity studies. J Ethnopharmacol 2021;268:113566. [PMID: 33166629 DOI: 10.1016/j.jep.2020.113566] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
21 Wan J, Wang J, Zhou M, Rao Z, Ling X. A cell membrane vehicle co-delivering sorafenib and doxorubicin remodel the tumor microenvironment and enhance immunotherapy by inducing immunogenic cell death in lung cancer cells. J Mater Chem B 2020;8:7755-65. [PMID: 32735004 DOI: 10.1039/d0tb01052a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]